You are here

  • Home
  • Archive
  • Volume 70, Issue 12
  • Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12

Article metrics

Article menu
Download PDFPDF
Original article
Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12

 

Online download statistics by month:

Online download statistics by month: July 2017 to March 2024

AbstractFullPdf
Jul 2017272810
Aug 20172501524
Sep 2017136319
Oct 2017136822
Nov 20173103624
Dec 20173843026
Jan 20182051912
Feb 201812074
Mar 20182892814
Apr 20184363210
May 201841395
Jun 2018207105
Jul 201812575
Aug 201810174
Sep 201812131
Oct 20185785
Nov 20188041
Dec 20189165
Jan 20196942
Feb 20197054
Mar 20191161011
Apr 20195630
May 20193032
Jun 20194132
Jul 20194662
Aug 20193463
Sep 20193843
Oct 20196156
Nov 20193200
Dec 20193542
Jan 20205441
Feb 20204942
Mar 20205054
Apr 20204722
May 20202602
Jun 20202630
Jul 20203211
Aug 20203111
Sep 20205255
Oct 20204521
Nov 20203321
Dec 20206459
Jan 20213120
Feb 20214145
Mar 20212021
Apr 20214802
May 202111621
Jun 2021554
Jul 2021932
Aug 2021841
Sep 2021321
Oct 20213331
Nov 20216911
Dec 20213422
Jan 20225150
Feb 20223512
Mar 20222500
Apr 20222221
May 20225500
Jun 202210752
Jul 20225242
Aug 20226300
Sep 20227250
Oct 202210142
Nov 20224530
Dec 20224410
Jan 20231011
Feb 20236640
Mar 20231000
Apr 20233021
May 20232801
Jun 20233410
Jul 202314220
Aug 20231821
Sep 20231001
Oct 20231700
Nov 20232431
Dec 20232810
Jan 20241800
Feb 20246910
Mar 20243820
Total6501406298